text: SECTION 1. SHORT TITLE.
  
      This Act may be cited as the ``21st Century Global Health 
  Technology Act''.
  
  SEC. 2. FINDINGS.
  
      Congress makes the following findings:
              (1) Applied research and development is a critical 
          component of United States leadership in global health. 
          Research and innovation can help to break the cycle of aid 
          dependency by providing sustainable solutions to long-term 
          problems. Research and development for global health is crucial 
          for meeting new and emerging challenges, creating efficiencies, 
          strengthening health systems, shifting tasks and strengthening 
          workforces, and increasing access to health services for the 
          most vulnerable. Research suggests that advances in health and 
          medical technologies have been the major drivers behind massive 
          improvements in health worldwide over the past century, 
          resulting in an average increase in life expectancies of 21 
          years in low- and middle-income countries between 1960 and 
          2002.
              (2) Because of its presence in the field, the United States 
          Agency for International Development (USAID) is uniquely placed 
          to assess local health conditions, then partner with public and 
          private stakeholders to ensure the development and timely 
          introduction and scale-up of tools that are culturally 
          acceptable, address serious and all-too-common health problems, 
          and contribute to the strengthening of health systems. In a 
          recent report to Congress, USAID calls health research 
          ``integral'' to its ``ability to achieve its health and 
          development objectives worldwide'' and states that innovation 
          through research allows the agency ``to develop and introduce 
          affordable health products and practices and contribute to 
          policies appropriate for addressing health-related concerns in 
          the developing world''. In 2006, USAID outlined a five-year 
          health research strategy: ``Report to Congress: Health-Related 
          Research and Development Activities at USAID (HRRD), May 
          2006'', with a timeline through 2010.
              (3) Congress notes the interrelated initiatives that USAID 
          has taken to advance science, technology, and innovation for 
          development, including the Grand Development Challenges, the 
          Innovation Fund, Development Innovation Ventures, the 
          Development Lab, and the Innovation Fellowship.
              (4) Applied research and development at USAID--
                      (A) facilitates public-private collaboration in the 
                  development of global health technologies;
                      (B) leverages public and private sector support for 
                  early stage research and development of health 
                  technologies to encourage private sector investment in 
                  late-stage technology development and product 
                  introduction in developing countries;
                      (C) benefits the United States economy by investing 
                  in the growing United States global health technology 
                  sector, which--
                              (i) provides skilled jobs for American 
                          workers;
                              (ii) creates opportunities for United 
                          States businesses in the development and 
                          production of new technologies; and
                              (iii) enhances United States 
                          competitiveness in the increasingly 
                          technological and knowledge-based global 
                          economy; and
                      (D) enhances United States national security by--
                              (i) reducing the risk of pandemic disease; 
                          and
                              (ii) contributing to economic development 
                          and stability in developing countries.
              (5) Investments by the United States in affordable, 
          appropriate health technologies, such as medical devices for 
          maternal, newborn, and child care; new vaccines; new vaccine 
          technologies and delivery tools; safe injection devices; 
          diagnostic tests for infectious diseases; new tools for water, 
          sanitation, and nutrition; multipurpose prevention 
          technologies; information systems and mobile health and 
          information systems; and innovative disease prevention 
          strategies--
                      (A) reduce the risk of disease transmission;
                      (B) accelerate access to life-saving global health 
                  interventions for the world's poor;
                      (C) reduce the burden on local health systems; and
                      (D) have been found by the United States Government 
                  and the World Health Organization to result in 
                  significant cost savings for development assistance 
                  funds.
              (6) Product development partnerships (PDPs) are one model 
          that is successfully accelerating research to benefit the 
          developing world. PDPs are non-profit, nongovernmental entities 
          that work to accelerate the development of new tools to fight 
          diseases in resource-poor settings. Typically, PDPs manage 
          resources and partnerships from across public, private, and 
          philanthropic sectors to drive the development of a full 
          pipeline of potential new products that could save and improve 
          lives in the developing world. USAID has played a significant 
          role in advancing the PDP model through its financial support. 
          Over the past decade, the achievements of PDPs have become 
          increasingly successful at advancing new products through the 
          development pipeline towards registration, product 
          introduction, and use.
              (7) Through a cooperative agreement, known as the Health 
          Technologies program, USAID supports the development of 
          technologies that--
                      (A) maximize the limited resources available for 
                  global health; and
                      (B) ensure that products and medicines developed 
                  for use in low-resource settings reach the people that 
                  need such products and medicines.
          Through the Health Technologies program, 85 technologies have 
          been invented, designed, developed, or co-developed, with many 
          of these technologies moved to global use and billions of units 
          used worldwide. Over its 25-year history, more than 95 private-
          sector collaborators have been involved in the Health 
          Technologies program, matching USAID dollars two to one.
              (8) USAID's translational research is complementary to the 
          work of other agencies:
                      (A) The Quadrennial Development and Diplomacy 
                  Review (QDDR) proposes to transition leadership of the 
                  Global Health Initiative (GHI) to USAID with a target 
                  date of the end of 2012. A core principle of the GHI is 
                  ``Research and innovation''.
                      (B) The Presidential Policy Directive on Global 
                  Development identifies innovation as contributing to 
                  the resolution of ``long-standing development 
                  challenges''.
                      (C) The QDDR affirms that ``US leadership in 
                  science and innovation is often linked to our ability 
                  to contribute to a safer, healthier, and more stable 
                  world.''.
  
  SEC. 3. PURPOSES.
  
      The purpose of this Act is to codify the cooperative agreement, 
  known as the Health Technologies program, in effect as of the date of 
  the enactment of this Act, under which the United States Agency for 
  International Development supports the development of technologies for 
  global health to--
              (1) improve global health;
              (2) reduce maternal, newborn, and child mortality rates;
              (3) reverse the incidence of HIV/AIDS, malaria, 
          tuberculosis, and other infectious diseases;
              (4) reduce the burden of chronic diseases; and
              (5) support research and development that is consistent 
          with a global development strategy and other related strategies 
          developed by USAID.
  
  SEC. 4. CODIFICATION OF HEALTH TECHNOLOGIES PROGRAM.
  
      Section 107 the Foreign Assistance Act of 1961 (22 U.S.C. 2151e) is 
  amended by adding at the end the following:
      ``(c) Health Technologies Program.--(1) There is established in the 
  United States Agency for International Development (USAID) a health 
  technologies program (referred to in this subsection as the `program').
      ``(2) The program shall develop, advance, and introduce affordable, 
  available, and appropriate and primarily late-stage technologies 
  specifically designed to--
              ``(A) improve the health and nutrition of populations in 
          developing countries;
              ``(B) reduce maternal, newborn, and child mortality in such 
          countries; and
              ``(C) improve the diagnosis, prevention, and reduction of 
          disease, especially HIV/AIDS, malaria, tuberculosis, and other 
          infectious diseases, in such countries.
      ``(3) The program shall be carried out under a cooperative 
  agreement between USAID and one or more institutions with a successful 
  record of--
              ``(A) advancing the technologies described in paragraph 
          (2); and
              ``(B) integrating practical field experience into the 
          research and development process in order to introduce the most 
          appropriate technologies.
      ``(4) The provisions of this subsection codify the cooperative 
  agreement, known as the Health Technologies program, in effect as of 
  the date of the enactment of this subsection, under which USAID 
  supports the development of technologies for global health. The 
  provisions of this subsection do not establish a new cooperative 
  agreement or program for such purposes.''.
  
  SEC. 5. REPORT ON RESEARCH AND DEVELOPMENT ACTIVITIES AT USAID.
  
      (a) In General.--The Administrator of the United States Agency for 
  International Development (referred to in this subsection as ``USAID'') 
  shall submit to Congress an annual report on research and development 
  activities at USAID.
      (b) Matters To Be Included.--The report required by subsection (b) 
  shall describe--
              (1) updates on its strategy for using research funds to 
          stimulate the development and introduction of key products;
              (2) USAID's collaborations and coordination with other 
          Federal departments and agencies in support of translational 
          and applied global health research and development;
              (3) its investments for the fiscal year in science, 
          technology, and innovation;
              (4) how these technologies and research products complement 
          the work being done by other Federal departments and agencies, 
          if applicable; and
              (5) technologies and research products that have been 
          introduced into field trials or use.
target: 21st Century Global Health Technology Act - Amends the Foreign Assistance Act of 1961 to establish in the United States Agency for International Development (USAID) the Health Technology Program which shall: (1) develop and introduce technologies designed to improve health and nutrition in developing countries, reduce maternal, newborn, and child mortality, and improve disease diagnosis and prevention, especially HIV/AIDS, malaria, tuberculosis, and other infectious diseases; and (2) be carried out under a cooperative agreement between USAID and one or more institutions with a successful record of advancing such technologies and integrating practical field experience into the research and development process.
  
  Codifies the Program.
feat_title: To amend the Foreign Assistance Act of 1961 to codify the cooperative agreement, known as the Health Technologies program, under which the United States Agency for International Development supports the development of technologies for global health, and for other purposes.